Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Clinical Study on the Efficacy and Safety of STSP-0601 for Injection in Patients With Hemophilia Associated With Inhibitors, With a Multicenter, Open Evaluation Approach

NCT06922045 is registered in ClinicalTrials.gov with Jiangsu BioJeTay Biotechnology Co., Ltd. as lead sponsor.

NCT NCT06922045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06922045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Clinical Study on the Efficacy and Safety of STSP-0601 for Injection in Patients With Hemophilia Associated With Inhibitors, With a Multicenter, Open Evaluation Approach
Lead sponsor
Jiangsu BioJeTay Biotechnology Co., Ltd.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 26, 2025
Completion date
March 31, 2027
Enrollment
40 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia